ISSX 2025 International Meeting

Trusted by 200+ pharmaceutical and biotech companies, as well as regulatory agencies, Certara’s Drug Interaction Database (DIDB®) provides unparalleled access to qualitative and quantitative human in vitro and clinical data. By incorporating information on extrinsic and intrinsic factors such as co-medications, excipients, food products, natural products, organ impairment, and genetics, DIDB® enables informed decision-making and supports the development of safer, more effective therapies.

Visit our booth for a demo of DIDB’s dynamic research tool’s and applications:

• Retrieve information using 70+ pre-formulated queries
• Optimize and validate PBPK models and static predictions
• Support drug labeling recommendations
• Calculate clinical DDI risk using static prediction models and generate submission-ready reports
• Quickly identify relevant concomitant medications
• Gain insights beyond DDIs

The Simcyp PBPK Simulator is the industry leader and most widely adopted platform for PBPK modeling in drug development. Developed through the expertise of a 25 year-long consortium involving 37 leading global pharmaceutical companies, the Simcyp PBPK Simulator is recognized and licensed by 11 regulatory agencies worldwide.